Publication | Open Access

Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers

VaccinationCancer ImmunosurveillanceBreast OncologyDisease StabilizationImmunologyTumor ImmunityTherapeutic VaccineImmunoeditingImmune Checkpoint InhibitorBreast CancerDendritic Cell BiologyImmunotherapyMedicineRadiation OncologyResponse Biomarkers